Antibiotic dosing for pneumonia in non-critical patients
Part of Infections, Lungs & breathing clinical trials.
This study is testing whether a certain dose of ceftriaxone, an antibiotic given intravenously, works well for people with pneumonia who are not severely ill. Participation could help doctors find the best dose for treating pneumonia without needing intensive care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated for pneumonia in an emergency room or within the first 3 days of being in the hospital.
- Your doctor has prescribed the antibiotic ceftriaxone for your pneumonia.
- You are not being admitted to an intensive care unit (ICU) for your current illness.
- You do not need a breathing machine or high-flow oxygen support right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a way to give antibiotics directly to the lungs (inhaled or nebulized) for people hospitalized with moderate to severe pneumonia. The goal is to see if this local treatment works better than standard antibiotics alone and helps you recover faster.
This trial compares different antibiotic strategies for children with pneumonia who are being treated as outpatients. The goal is to find the best approach to treat the infection and help your child recover.
This trial studies how a common antibiotic (ceftriaxone) is processed in the body of brain-injured patients on breathing machines, to find the best dose for preventing early pneumonia. It may help improve care and outcomes for people with serious brain injuries.
This trial compares how long antibiotics should be given to people hospitalized with moderately severe community-acquired pneumonia. It uses your early improvement to see which antibiotic duration works best and safely.
This trial compares two antibiotics, azithromycin and doxycycline, when given alongside a standard beta-lactam antibiotic to hospitalized adults with community-acquired pneumonia. It aims to see which combination works better and is safer.
This study looks at whether giving two antibiotics together is better for people hospitalized with severe pneumonia. It may help doctors choose the most effective treatment.
Hear when a new Community Acquired Pneumonia (CAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.